Metrion provides stable cell reagent generation services and an extensive catalogue of assay-ready ion channel cell reagents for drug discovery research. We develop both ready-to-use and custom-engineered cell reagents, including complex multi-subunit ion channel models, to support target validation, assay development, compound screening and pharmacological profiling.
Clients trust us to develop robust cell reagents, giving consistent, reproducible, and biologically relevant data, which significantly enhances the efficiency, reliability, and success rate of identifying new therapeutic agents.
Investing in the generation of high-quality cell reagents reduces costs over time by reducing the need for repeat experiments and minimising the risk of failed drug candidates due to unreliable data.
By following processes meticulously, Metrion ensures that cell reagents are biologically relevant and consistently deliver advanced and relevant insights into human diseases and potential therapies:
Our molecular biology team has more than 30 years of combined experience in stable cell reagent generation for high-throughput screening and compound profiling, recombinant DNA technologies and assay-ready cell reagent development.
We have successfully generated cell reagents expressing simple and complex multi-subunit ion channel targets for pharmaceutical, biotechnology and academic organisations worldwide.
Access reliable, assay-ready cells for functional screening and characterisation studies, supported by specialist cell biology expertise.
Combining specialist cell biology expertise with advanced electroporation technology, we achieve highly efficient, scalable and reproducible transfection across a wide range of cell types, including difficult-to-transfect cell reagents and iPSC-derived cells.
This enables the rapid generation of cells expressing wild-type or mutant ion channels, providing consistent cellular material for the development of robust functional assays.
Our high-throughput capabilities can also support the evaluation of ion channel variants, helping researchers characterise disease-associated mutations, investigate pharmacological responses and identify compounds with selective activity.
From initial cell generation through to assay-ready material, our scientists work closely with you to deliver the quality, consistency and reproducibility required for your ion channel studies.
Cell reagent generation for ion channel drug discovery is the process of creating stable cell lines that express a specific ion channel target. These engineered cells provide a reliable in vitro model for studying ion channel function, screening compounds, and evaluating drug potency, selectivity, and mechanism of action.
A stable cell line is a population of cells that has been genetically engineered to permanently express a target gene. Stable cell lines provide consistent performance across drug discovery and screening programmes.
What are the benefits of stable cell line generation?
Metrion specialises in ion channels and can also support projects involving receptors, transporters and complex multi-subunit targets.
Yes. Metrion has extensive experience generating cell lines expressing complex multi-subunit ion channels and other challenging membrane proteins.
Stable cell lines provide reproducible target expression, improving assay reliability and increasing confidence in screening and profiling data.